Chembio Diagnostics, Inc.CE.MINASDAQ
Loading
Price to Sales: Premium ValuationElevated
Percentile Rank100
3Y CAGR+10.3%
5Y CAGR+10.2%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
+10.3%/yr
vs +1.4%/yr prior
5Y CAGR
+10.2%/yr
Consistent
Acceleration
+8.9pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
1.6x
Solid growth
Streak
2 yr
Consecutive growthElevated
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 1.72 | +42.0% |
| 2024 | 1.21 | +21.2% |
| 2023 | 1.00 | -22.1% |
| 2022 | 1.28 | +3.6% |
| 2021 | 1.24 | +17.1% |
| 2020 | 1.06 | -11.7% |
| 2019 | 1.20 | -1.3% |
| 2018 | 1.21 | -29.4% |
| 2017 | 1.72 | +22.0% |
| 2016 | 1.41 | - |